MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

37

MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM 5.03

AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES IN FISCAL YEAR.

On December 21, 2017, following the completion of the exchange of Series L convertible preferred stock (the “Series L Preferred Stock”) for all outstanding Series F convertible preferred stock (the “Series F Preferred Stock”), Series G convertible preferred stock (the “Series G Preferred Stock”) and Series H convertible preferred stock (the “Series H Preferred Stock”) and related documentation, MabVax Therapeutics Holdings, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificates of Elimination eliminating from its Amended and Restated Certificate of Incorporation the designation of shares of its preferred stock as Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock. As a result, all shares of preferred stock previously designated as Series F, Series G and Series H Preferred Stock were eliminated and returned to the status of authorized but unissued shares of preferred stock, without designation.

As previously disclosed in a current report on Form 8-K filed on October 19, 2017, the Series F, Series G, and Series H Preferred Stock were exchanged for newly authorized Series L Preferred Stock to exchange agreements entered into and consummated on October 18, 2017.

A copy of the Certificate of Elimination for the Series F, Series G and Series H Preferred Stock is included in this Current Report as Exhibit 3.1, the contents of which are each hereby incorporated by reference.

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit No.

Description

Certificate of Elimination of Series F, Series G, and Series H Preferred Stock


MABVAX THERAPEUTICS HOLDINGS, INC. Exhibit
EX-3.1 2 ex3-1.htm CERTIFICATE OF ELIMINATION OF SERIES F,…
To view the full exhibit click here

An ad to help with our costs